Bretschneider Henriette, Quade Mandy, Lode Anja, Gelinsky Michael, Rammelt Stefan, Zwingenberger Stefan, Schaser Klaus-Dieter, Vater Corina
University Center of Orthopaedics and Traumatology, University Hospital Carl Gustav Carus of Technische, Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine of Technische, Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Int J Mol Sci. 2020 Feb 19;21(4):1412. doi: 10.3390/ijms21041412.
In this study, the bone-regenerative potential of bioactive factors derived from adipose tissue, platelet-rich plasma (PRP) and conditioned medium from hypoxia-treated human telomerase immortalized bone-marrow-derived mesenchymal stem cells (hTERT-MSC) was investigated in vitro with the aim to develop cost-effective and efficient bone substitutes for optimized regeneration of bone defects. Adipose tissue was harvested from human donors undergoing reconstructive surgery, and adipose tissue extract (ATE) was prepared. Platelet lysates (PL) were produced by repeated freeze-thaw cycles of PRP, and hypoxia-conditioned medium (HCM) was obtained by culturing human telomerase immortalized bone-marrow-derived mesenchymal stromal cells for 5 days with 1% O2. Besides analysis by cytokine and angiogenesis arrays, ELISA was performed. Angiogenic potential was investigated in cocultures of bone-marrow-derived (BM)-MSC and human umbilical vein endothelial cells. Multiple angiogenic proteins and cytokines were detected in all growth factor mixtures. HCM and ATE contained high amounts of angiogenin and CCL2/MCP-1, whereas PL contained high amounts of IGFBP-1. Culturing cells with HCM and ATE significantly increased specific ALP activity of BM-MSC as well as tubule length and junctions of endothelial networks, indicating osteogenic and angiogenic stimulation. To achieve a synergism between chemoattractive potential and osteogenic and angiogenic differentiation capacity, a combination of different growth factors appears promising for potential clinical applications.
在本研究中,对源自脂肪组织、富血小板血浆(PRP)以及缺氧处理的人端粒酶永生化骨髓间充质干细胞(hTERT-MSC)的条件培养基的生物活性因子的骨再生潜力进行了体外研究,旨在开发具有成本效益且高效的骨替代物,以优化骨缺损的再生。从接受重建手术的人类供体中采集脂肪组织,并制备脂肪组织提取物(ATE)。通过对PRP进行反复冻融循环制备血小板裂解物(PL),通过在1%氧气条件下培养人端粒酶永生化骨髓间充质基质细胞5天获得缺氧条件培养基(HCM)。除了通过细胞因子和血管生成阵列进行分析外,还进行了酶联免疫吸附测定(ELISA)。在骨髓来源的(BM)-MSC与人脐静脉内皮细胞的共培养物中研究血管生成潜力。在所有生长因子混合物中均检测到多种血管生成蛋白和细胞因子。HCM和ATE含有大量血管生成素和CCL2/MCP-1,而PL含有大量胰岛素样生长因子结合蛋白-1(IGFBP-1)。用HCM和ATE培养细胞可显著提高BM-MSC的特异性碱性磷酸酶活性以及内皮网络的小管长度和连接,表明具有成骨和血管生成刺激作用。为了在趋化潜力与成骨和血管生成分化能力之间实现协同作用,不同生长因子的组合对于潜在的临床应用似乎很有前景。